Abstract:Phosphoinositide 3-kinases (PI3Ks) are lipid kinases essential for growth and metabolism. Their aberrant activation is associated with many types of cancers. Here we used single-particle cryoelectron microscopy (cryo-EM) to determine three distinct conformations of full-length PI3K alpha (p110 alpha-p85 alpha): the unliganded heterodimer PI3K alpha, PI3K alpha bound to the p110 alpha-specific inhibitor BYL-719, and PI3K alpha exposed to an activating phosphopeptide. The cryo-EM structures of unbound and of BYL-719-bound PI3K alpha are in general accord with published crystal structures. Local deviations are presented and discussed. BYL-719 stabilizes the structure of PI3K alpha, but three regions of low-resolution extra density remain and are provisionally assigned to the cSH2, BH, and SH3 domains of p85. One of the extra density regions is in contact with the kinase domain blocking access to the catalytic site. This conformational change indicates that the effects of BYL-719 on PI3K alpha activity extend beyond competition with adenosine triphosphate (ATP). In unliganded PI3K alpha, the DFG motif occurs in the "in" and "out" positions. In BYL-719-bound PI3K alpha, only the DFG-in position, corresponding to the active conformation of the kinase, was observed. The phosphopeptide-bound structure of PI3K alpha is composed of a stable core resolved at 3.8 angstrom. It contains all p110 alpha domains except the adaptor-binding domain (ABD). The p85 alpha domains, linked to the core through the ABD, are no longer resolved, implying that the phosphopeptide activates PI3K alpha by fully releasing the niSH2 domain from binding to p110 alpha. The structures presented here show the basal form of the full-length PI3K alpha dimer and document conformational changes related to the activated and inhibited states.

X-ray structure of the SH3 domain of the phosphoinositide 3-kinase p85[beta] subunit

X-ray structure of the SH3 domain of the phosphoinositide 3-kinase p85β subunit.

Crystal Structure of the N-Terminal Sh3 Domain of Mouse Beta Pix, P21-Activated Kinase-Interacting Exchange Factor

Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding

Cryo-EM structures of PI3K reveal conformational changes during inhibition and activation

Architecture of the human PI4KIIIα lipid kinase complex

Crystal Structure of the C2 Domain of Class II Phosphatidylinositide 3-Kinase C2α

Functional selection in SH3-mediated activation of the PI3 kinase

Computational Insights into the Interactions between Calmodulin and the c/nSH2 Domains of p85α Regulatory Subunit of PI3Kα: Implication for PI3Kα Activation by Calmodulin.

Structural Investigation of the Interaction Between the Tandem SH3 Domains of C-Cbl-associated Protein and Vinculin.

Solution Structure Of The Sh3 Domain Of Dock180

Molecular insights into the membrane-associated phosphatidylinositol 4-kinase IIα.

Structural basis for the Rho- and phosphoinositide-dependent localization of the exocyst subunit Sec3

Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)

Understanding the Selectivity of Inhibitors Toward PI4KIIIα and PI4KIIIβ Based Molecular Modeling

Homology modeling and molecular dynamics study of GSK3/SHAGGY-like kinase.

NMR structure and regulated expression in APL cell of human SH3BGRL3.

Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα

Homology modeling and molecular dynamics study of GSK3/SHAGGY-like kinase

Dynamic Molecular Architecture and Substrate Recruitment of Cullin3–ring E3 Ligase CRL3KBTBD2

Structural Recognition Mechanisms Between Human Src Homology Domain 3 (SH3) and ALG-2-interacting Protein X (Alix).